This study shows that in the glioblastoma hamster cell line HJC12 the retinoblastoma family member pRb2/ p130 enhances g-radiation-induced cell death. In HJC12 cells the tetracycline-regulated expression of pRb2/p130 increased the percentage of g-radiation-induced apoptotic cells from 27 to 47%. pRb2/p130 overexpression was associated with the downregulation of the anti-apoptotic factor Bcl-2 and the upregulation of the steady-state protein levels of the pro-apoptotic transcription factor p73. In particular, RT -PCR showed a significant increase in the expression of the p73d isoform when pRb2/p130 was overexpressed. The ability of pRb2/p130 to modulate apoptosis was not associated with its role in mediating G0/G1 arrest during cell cycle progression. Our data suggest a role for pRb2/p130 in glioblastoma g-radiation-induced cell death, indicating that the antitumoral action of pRb2/p130 can regulate both inhibition of cell cycle progression and induction of cell death.
Introduction pRb2/p130, originally identified in our laboratory, is a member of the retinoblastoma family along with pRb/ p105 and p107 (Stiegler and Giordano, 1998) . Similarly to its homologues, pRb2/p130 is a tumor suppressor that negatively regulates cell cycle progression. As a member of the retinoblastoma family, pRb2/p130 interacts with cyclin-dependent kinases (cdks) and binds E2F transcription factors, in particular E2F-4, and inhibits S phase gene transcription. pRb2/p130 is regulated by cdks through phosphorylation. Hyperphosphorylated pRb2/p130 loses its ability to inhibit E2F-4 transcription factors and to block cell cycle progression. Upon dephosphorylation, pRb2/p130 is activated and induces growth arrest at the G0/G1 phase of the cell cycle. pRb2/p130 is mainly expressed and active in arrested or differentiated cells (MacLachlan et al., 1995) .
Increasing evidence has indicated that Rb family proteins, including pRb/p105, are not only involved in proliferation and transformation but also in apoptosis. Indeed, pRb/p105 has a protective function against apoptosis. In vivo studies show that pRb/p105 knockout mice die in utero at 14 -15 days with defects in the haematopoietic system and impaired development of the central and peripheral nervous system because of massive cell death (Jacks et al., 1992) . Inappropriate cell death is also present in the liver, lens and skeletal muscle precursors. In vitro experiments confirm the results obtained with transgenic mice. TGF-b1 causes cell death by suppressing the expression of pRb/p105 and by phosphorylating it (Fan et al., 1996) . Similarly, IFNg-induced apoptosis is blocked in pRb/p105-positive cells (Berry et al., 1996) . Restoring the function of pRb/p105 in a pRb/105-null osteosarcoma cell line inhibits irradiation-induced apoptosis (Haas-Kogan et al., 1995) . Additional support for a protective role for pRb/ p105 against apoptosis comes from the observation that pRb/p105 is cleaved by caspases during apoptosis (An and Dou, 1996; Dou et al., 1997; Janicke et al., 1996) . Not many data are currently available on the role of the other two members of the Rb family, pRb2/p130 and p107, in apoptosis.
In the present study, we examine the role of pRb2/ p130 in g-radiation-induced apoptosis by using the hamster glioblastoma cell line HJC12, which was irradiated in the presence of tetracycline-regulated pRb2/p130 expression.
Results

g-radiation-induced apoptosis in HJC12 cell line is enhanced by pRb2/p130
To investigate the effect of pRb2/p130 overexpression in g-radiation-induced apoptosis we used a tetracyclineregulated gene expression system (Tet -Off) that controls expression of the encoded protein pRb2/p130 in JC virus-induced hamster brain tumor cells, namely the glioblastoma cell line HJC12 (Howard et al., 1998) . Since radiation-induced apoptosis is mediated predominantly by p53, we selected a cell line in which both p53 and pRb/p105 are inactivated (Ray et al., 1995) . This mimics the inactivation of p53 and pRb/p105 (by mutations or viruses) often found in clinical settings, thus rendering the results more relevant for possible therapeutic exploitation. Indeed, in the HJC12 cell line JCV T-antigen inactivates the endogenous Rb family members, as well as p53.
g-Radiation affects HJC12 cell proliferation, as seen qualitatively by phase contrast microscopy ( Figure  1A ). Cells were exposed to 10 Gy of g-radiation in the presence (left panels) or absence (right panels) of tetracycline and pictures were taken after 2 and 5 days. The morphology of untreated cells, grown in the presence ( Figure 1A ,a) or absence ( Figure 1A ,b) of tetracycline, showed that these cells were healthy. In irradiated HJC12 cells, cell death was visible after 2 days ( Figure 1A ,c,d) and 5 days ( Figure 1A ,e,f).
DNA laddering shows that irradiation-induced cell death occurs in HJC12 by apoptosis in the presence ( Figure 1B ,a) or absence ( Figure 1B,b ) of tetracycline. Lower doses, 4 and 8 Gy, were also tested, but no significant ladder was observed at 2 and 5 days (data not shown). The induction of apoptosis was further confirmed by the cleavage of poly(ADP-ribose)polymerase (PARP), as a marker of activation of caspase-3-like ( Figure 1C ).
Phase contrast microscopy and DNA laddering are not quantitative methods for apoptosis. We performed flow cytometric analysis on HJC12 cells in order to quantify the kinetics of apoptosis. The average percentage of apoptotic events in untreated HJC12 cells was 3.4 and 5.7% in the presence and the absence of tetracycline, indicating that pRb2/p130 per se could facilitate apoptosis. Five days after irradiation these percentages increased to 27 and 47%, respectively. The increase in apoptotic events induced by pRb2/p130 during g-radiation is shown in Figure 2 .
To determine whether the enhanced apoptosis in cells overexpressing pRb2/p130 correlated with differences in cell cycle response to irradiation, we analysed cell cycle distribution at 2 and 5 days after exposure to 10 Gy of irradiation (Table 1) . As previously reported, results indicate a progressive G2/M accumulation after radiation (Muschel et al., 1998) , an effect which could be linked to the loss of p53 function (Haas-Kogan et al., 1995; Strasser-Wozak et al., 1998) . Even though pRb2/p130 overexpression induced a G0/G1 accumulation, the irradiation-dependent accumulation in G2/M became significantly more evident over time.
Contact inhibition blocked HJC12 cells in G0/G1 but did not enhance radiation-induced apoptosis
Although the HJC12 cells overexpressing pRb2/p130 exhibited no radiation-induced G0/G1 arrest, we investigated whether the ability of pRb2/p130 to modulate apoptosis might, nevertheless, be associated with the reported role of pRb2/p130 in mediating G0/ G1 arrest during cell cycle progression (Claudio et al., 1994) . We used contact inhibition to induce a G0/G1 arrest in HJC12 cells grown in the presence of tetracycline. G0/G1 arrested cells were irradiated (10 Gy) and collected after 2 and 5 days. Flow cytometric analysis showed no significant increase of apoptotic events in G0/G1 arrested irradiated cells (Figure 2 ), compared with the cycling cells grown with tetracycline. In HJC12 cells irradiation induced a G0/ G1 arrest after 5 days, followed by a slight increase in apoptosis (29.3%), when compared to the increase induced by pRb2/p130 overexpression (47%). An increase in apoptotic bodies also was observed in G0/G1 arrested cells before irradiation (9.8%) with respect to normal cycling cells (3.4%), an effect possibly caused by the stressing condition of hyperconfluence.
To confirm that cells were blocked in G0/G1 by contact inhibition, cell cycle analysis was performed before and after 10 Gy of g-radiation (Table 2) . Contact inhibition successfully arrested the cells in G0/G1 (70.6%). After 2 and 5 days, the percentages of G0/G1 cells were 61.5% and 53.3%, respectively. pRb2/p130 alters the expression of pro-and antiapoptotic proteins during irradiation-induced apoptosis
We investigated the role of several proteins involved in apoptosis in order to understand the molecular mechanism through which pRb2/p130 sensitizes the HJC12 cells to death. We compared them with the steady-state protein levels of pRb2/p130 in Tet -On Tet -Off cultures before and after 10 Gy of g-radiation.
The CD95(APO-1/Fas) receptor and ligand system plays a crucial role in growth control by mediating apoptosis in lymphoid and non-lymphoid cells (Zhivotovsky et al., 1997; Debatin et al., 1997) , also following radiation (Sheard et al., 1999; Mo and Beck, 1999) . We therefore investigated the potential involvement of the CD95/CD95L pathway in our model. We did not observe any alteration in the steady-state protein levels of either CD95 ( Figure 3A ,b) or CD95L ( Figure 3A ,c) during the treatments.
We analysed protein steady-state of Bcl-2 family proteins, Bax, Bcl-x L and Bcl-2 (Gross et al., 1999) . No significant alterations were found in Bcl-x L ( Figure  3B ,b) or Bax ( Figure 3A,d ) protein levels after the 10 Gy of irradiation. However, Bcl-2 protein levels were significantly lower in dying cells that overexpressed pRb2/p130 protein ( Figure 3B,a) . pRb2/ Figure 3C ,a), suggesting that the protein level is controlled by protein stability rather than at the transcriptional level. No alteration was observed in Bax and Bcl-x L mRNA levels (data not shown). pRb2/p130 and b-actin mRNA expression, evaluated by RT -PCR also is shown as a control ( Figure 3C ,b and c, respectively). The protein and mRNA expression level of Bcl-2 was tested in the parental HJCD5 cells (Howard et al., 1998) in the presence or absence of tetracycline to prove that tetracycline does not increase the expression of Bcl-2 protein level ( Figure 4A and B, respectively), and consequently the decrease of Bcl-2 protein level in HJC12 cells grown in the absence of tetracycline was due to pRb2/p130 overexpression.
p73, a p53-related gene mediates apoptosis independent of p53, by an interaction with c-Abl Agami et al., 1999; Yuan et al., 1999; Ding et al., 1999) . This also occurs in g-radiation apoptosis in cells lacking p53. The regulation of p73 occurs by stabilization of the protein half-life. We tested the steady-state levels of p73 protein in our model. Western blot was performed on cellular extracts collected at the indicated times ( Figure  5A ,a). A 10-and a 9-fold increase in p73 protein level was observed 2 and 5 days, respectively, after irradiation when pRb2/p130 was induced in the cells (lanes 4 and 6). The p73 gene (TP73) is expressed in several distinct isoforms arising from alternative splicing of the 3'-end exons. We therefore investigated which isoform was expressed and modulated in our model by performing a quantitative radioactive RT -PCR to determine the relative mRNA expression of the several p73 isoforms (De Laurenzi et al., 1998 . This approach also allowed us to investigate the possibility that pRb2/p130 induces p73 expression through a transcriptional mechanism. We performed a radioactive PCR in HJC12 cells 8, 24 and 48 h after 10 Gy of irradiation. Several different p73 isoforms were identified: a, b, g ( Figure 5B ,a) and d ( Figure  5B ,b). b-actin mRNA expression was also evaluated by radioactive PCR ( Figure 5B ,c). mRNA expression of both a and d p73 subunits peaks at 24 h. Even though a selective modulation of the d isoform has been already described in a different context (De Laurenzi et al., 2000) , its physiological role is unclear. In addition to these observed transcriptional changes, still we have to remember that the steady-state levels of p73 protein can be also controlled by protein stability .
Discussion
Our data demonstrate a novel pro-apoptotic function of the cell cycle regulator pRb2/p130. In our cellular model, induced overexpression of pRb2/p130 increases the percentage of apoptotic cells after g-radiation. We show that the ability of pRb2/p130 to modulate apoptosis is not associated with its role in mediating G0/G1 arrest during cell cycle progression, since HJC12 cells overexpressing pRb2/p130 exhibit no radiation-induced G0/G1 arrest. In addition, no increase in radiation-induced apoptosis is noted in HJC12 cells arrested in G0/G1 by contact inhibition. p53 and the endogenous Rb family proteins are not involved in this apoptotic response, because JCV Tantigen inactivates them.
In irradiated HJC12 cells, pRb2/p130 overexpression leads to a decrease in the Bcl-2 steady-state level. Bcl-2 protein downregulation leads to an imbalance of proanti-apoptotic heterodimers of the Bcl-2 family members present on the mitochondrial membrane, thus favoring the formation of pro-apoptotic homodimers Figure 2 pRb2/p130 causes an increase of apoptosis in g-irradiated HJC12 independent of G0/G1 arrest. Increase of apoptotic bodies in 10 Gy irradiated HJC12 cells at different times as detected by flow cytometry. The data are expressed as the mean (+s.d.) of three different determinations, each performed in duplicates. Error bars were omitted when their value was too small to be reported De Laurenzi et al., 1998 , induces apoptosis (Jost et al., 1997) . This death pathway is independent of and parallel to p53, being mediated by c-Abl tyrosine kinase activity Agami et al., 1999; Yuan et al., 1999) . In irradiated HJC12 cells, p73 protein is induced at high levels when pRb2/p130 is overexpressed. This increase is obtained by an increase in the transcription of p73 mRNA but mainly by post-translational regulation Agami et al., 1999; Yuan et al., 1999) .
Our results show that pRb2/p130 is able to increase cell death by two mechanisms. First, pRb2/p130 turns off the anti-apoptotic factor, Bcl-2. Second, pRb2/p130 induces the accumulation of the pro-apoptotic protein p73. At present the details regarding the mechanism that connects pRb2/p130 to these two apoptotic regulators remain unknown. pRb2/p130, like other Rb family proteins, is responsible for transcriptional suppression of a series of genes involved in G1/S phase transition (Stiegler and Giordano, 1998) . We hypothesize that pRb2/p130 may regulate apoptosis with the same mechanism, by repressing the expression of genes involved in Bcl-2 stabilization or p73 degradation. The transcriptional suppression mediated by the Rb family proteins is due to the binding of their hypophosphorylated form to E2F transcription factors. Different members of the E2F family bind different Rb family proteins, each in a different order, during the cell cycle. pRb2/p130 is primarily active in arrested G0/G1 or in differentiated cells and it binds the E2F-4 factor (Stiegler and Giordano, 1998) . In the presence of growth factors, cells re-enter the cell cycle. For this purpose Cdk4-6/cycD complexes hyperphosphorylate pRb2/ p130, inactivate it, releasing the inhibition on E2F transcription. Subsequently, in late S phase pRb2/p130 is exported to the cytoplasm (Baldi et al., 1995; Nevins, 1998) and is degraded by the 26S proteosome (Nevins, 1998) . It has been demonstrated that pRb2/p130 can also associate and inhibit Cdk2/CycE and Cdk2/CycA complexes (De Luca et al., 1997) . It is possible that in our system a forced expression of pRb2/p130 during the cell cycle could suppress the transcription of genes or the Cdk phosphorylation of proteins involved in p73 and Bcl-2 degradation. For example, p73 activation depends on tyrosine phosphorylation by c-Abl kinase , which also could be regulated by pRb2/p130.
It has been shown that in G1 phase the promoter of p73 is regulated by E2F-1 to induce cell death in the absence of p53 (Irwin et al., 2000) . It is also conceivable that in G0 phase the absence of p53-dependent apoptosis could be bypassed by inducing p73 activation. In this phase, pRb2/p130 and its ligand E2F-4 may be responsible for p73 protein stabilization and for inducing its mRNA transcription. The stabilization of p73 could be the result of both the induction of a specific isoform (e.g. d) and the transcriptional suppression of genes involved in p73 degradation. In fact, it has been demonstrated that pRb2/p130-E2F4 complexes act as transcriptional repression factors in G0 phase (Stiegler and Giordano, 1998) . Clearly this hypothesis requires further experimental evaluation.
In multicellular organisms cell proliferation and cell death are regulated in order to maintain tissue homeostasis. Many investigations suggest that this regulation is achieved by directly coupling the process of cell cycle progression and programmed cell death by using and controlling a shared set of factors (Kasten and Giordano, 1998; Choisy-Rossi and YonishRouach, 1999; Vousden, 2000) . A solid argument in favor of a link between the cell cycle and apoptosis arises from the accumulated evidence that manipulation of the cell cycle may either prevent or induce an apoptotic response (Haas-Kogan et al., 1995; Bowen et al., 1998; Gil-Gomez et al., 1998; Harvey et al., 1998) . With regard to the Rb family proteins, data indicate the involvement of pRb/p105 in apoptosis. pRb/p105 plays the role of an anti-apoptotic factor in several systems such as in IFNg-induced apoptosis (Berry et al., 1996) and in X-ray-induced apoptosis (Haas-Kogan et al., 1995) . In addition, pRb/p105 is a target of caspases in several systems (An and Dou, 1996; Dou et Janicke et al., 1996) . Data also point to a pro-apoptotic role for pRb/p105 (Bowen et al., 1998; Knudsen et al., 1999) . There are no current data concerning the role of pRb2/p130 in apoptosis. However, pRb2/p1307/7 mice die during embryogenesis at 11 to 13 days and show defects in neural and dermamyotomal structures (LeCouter et al., 1998) . The lethality of pRb2/p130 null mutation is strain-dependent (Cobrinik et al., 1996) . Taking into consideration the results of the knockout, it is likely that pRb2/p130 plays an important role in apoptosis, one of the most important features of development.
In this study we demonstrate for the first time a role for pRb2/p130 in g-radiation-induced apoptosis, which seems to occur via p73. This suggests that artificial overexpression of pRb2/p130 (e.g., by gene therapy) may be used to improve radiotherapy results (Claudio et al., 2000) . The potential antitumoral action of pRb2/p130 could have clinical applications because the alternative pathways (namely p53 and pRb/p105) are very often mutated or virally inactivated in cancer. Thus pRb2/ p130 inhibits tumor progression not only by inhibiting cell cycle progression, as already demonstrated (Claudio et al., 1994) , but also by inducing cell death.
Materials and methods
Materials
Heat inactivated fetal bovine serum (FBS) was obtained from Sigma (St Louis, MO, USA). L-Glutamine (200 mM) and a mix of penicillin/streptomycin (10 000 I.U./ml and 10 000 mg/ ml, respectively) were purchased from Mediatech Inc. (Herdon, VA, USA). Protein concentration was assayed using the Bio-Rad protein assay based on the Bradford dyebinding procedure obtained from Bio-Rad laboratories (Hercules, CA, USA). Anti-human PARP polyclonal antibody (H-250), anti-human Bax polyclonal antibody (N-20), anti-human Bcl-2 monoclonal antibody (C-2), anti-human Bcl-x L polyclonal antibody (H-62), anti-human b-actin (C-7), and anti-human CD95 polyclonal antibody (FL-335) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-human CD95L monoclonal antibody was purchased from Transduction Laboratories (Lexington, KY, USA). The secondary horseradish peroxidase labeled goat anti-mouse and goat anti-rabbit antibodies were obtained from Amersham Life Science Inc. (Arlington Heights, IL, USA). Anti-human p73a/b monoclonal antibody (ER-15) was obtained from Neomarkers (Fremont, CA, USA).
Cell culture
The COS7 cell line was grown in monolayer cultures in Dulbecco -MEM media supplemented with 10% heat inactivated FBS, L-glutamine (2 mM), penicillin (100 I.U./ ml), streptomycin (100 mg/ml) at 378C in a humidified atmosphere of 5% CO 2 and 95% air. The hamster glioblastoma cell line HJC12 (p53 and pRb/p105 functionally inactivated), previously described (Howard et al., 1998) , was grown in monolayer cultures in Dulbecco -MEM media supplemented with 5% heat inactivated FBS. L-glutamine (2 mM), penicillin (100 I.U./ml), streptomycin (100 mg/ml), neomicin (500 mg/ml), and tetracycline (2 mg/ml) (Sigma Chemical Co.) at 378C in a humidified atmosphere of 5% CO 2 and 95% air. The cells were split every 3 days using 0.25% (v/v) trypsin (Gibco BRL, Gaithersburg, MD, USA) in versene buffer. Cells were tested routinely to be mycoplasma free.
For the experiments, 5610 5 HJC12 cells were plated on plastic dishes (100620 mm) and were allowed to attach. To allow the expression of pRb2/p130 in the absence of tetracycline, cells were irradiated 48 h after plating. Media were changed every 2 days to prevent tetracycline degradation and a consequently uncontrolled expression of pRb2/p130. Media were changed also after the irradiation. To avoid the loss of apoptotic bodies, old media were centrifuged and apoptotic bodies were resuspended in the new media.
For G0/G1 arrest by contact inhibition, cells were grown to confluence and then irradiated.
The HJCD5 cell line (Howard et al., 1998) was grown in monolayer cultures in Dulbecco -MEM media supplemented with 5% heat inactivated FBS, L-glutamine (2 mM), penicillin (100 I.U./ml), streptomycin (100 mg/ml), neomicin (500 mg/ ml), + or 7 tet (2 mg/ml) (Sigma Chemical Co.) as the experiments required at 378C in a humidified atmosphere of 5% CO 2 and 95% air. The cells were split every 3 days using 0.25% (v/v) trypsin (Gibco BRL, Gaithersburg, MD, USA) in versene buffer. Cells were tested routinely to be mycoplasma-free.
For the experiments, 5610 5 HJCD5 cells were plated in + tet or 7 tet and were allowed to attach on plastic dishes (100620 mm). Cells were irradiated 48 h after plating. Media were changed every 2 days to prevent tetracycline degradation.
Analysis of cell death
Three methods were used: Phase contrast microscopy, agarose-gel electrophoresis of purified DNA and flow cytometry.
Phase contrast microscopy
Morphology was evaluated after irradiation by phase contrast microscopy without preliminary fixation. Micrographs were produced using a Nikon phase contrast microscope.
Agarose-gel electrophoresis of purified DNA Cells irradiated at different intensities were collected at different times using 0.25% (v/v) trypsin and centrifuged at 2000 g for 10 min. After a wash in PBS (13.7 mM NaCl, 0.27 mM KCl, 0.43 mM Na 2 HPO 4 7H 2 O, 0.14 mM KH 2 PO 4 (pH 7.3)), each pellet was lysed in 500 ml of freshly made lysis buffer containing 10 mM Tris-HCl pH 8, 10 mM EDTA and 0.5% Triton X-100. The pellet then was incubated for 30 min in ice to allow complete cell lysis. After lysing, debris was removed by centrifugation at 13 000 g for 20 min at +48C and the supernatant was collected. DNase-free RNase (Sigma, St. Louis, MO, USA) was added to the supernatant at a final concentration of 0.2 mg/ml, which then was incubated at 378C for 30 min with gentle shaking. Proteinase K (Sigma) and SDS were added at a final concentration of 0.1 mg/ml and 1%, respectively. Proteinase K and SDS incubation was performed at 508C for 16 h. A Phenol/ Chloroform extraction was performed by centrifuging the samples at 2000 g. The DNA was precipitated in 0.3 M NaAcetate pH 5.2 and in 2 volumes of 100% ethanol at 7208C overnight. After a 50 min centrifugation at 13 000 g at +48C, the pellet was dried and resuspended in 30 ml of TE buffer (10 mM Tris-HCl and 1 mM EDTA, pH 8). The samples, together with a molecular weight standard (1 Kb DNA ladder, Gibco BRL, Gaithersburg, MD, USA), were loaded on a 1.2% (w/v) agarose gel containing 0.5 mg/ml ethidium bromide and an electrophoresis was performed. DNA laddering was observed on a transilluminator and Polaroid pictures were obtained.
Flow cytometry
After irradiation HJC12 cells were collected using 0.25% (v/ v) trypsin and were centrifuged at 2000 g for 10 min. Cells were fixed with 1 : 1 PBS (13.7 mM NaCl, 0.27 mM KCl, 0.43 mM Na 2 HPO 4 7H 2 O, 0.14 mM KH 2 PO 4 (pH 7.3)) and methanol-acetone (4 : 1 v/v) solution. Cells were washed in PBS (13.7 mM NaCl, 0.27 mM KCl, 0.43 mM Na 2 HPO 4 7-H 2 O, 0.14 mM KH 2 PO 4 (pH 7.3)). Then cells were incubated with 13 kU RNase (Sigma) for 20 min at 378C and with 40 mg/ml propidium iodide (Sigma) for 15 min at 378C. The apoptotic cells (hypodiploid events) were evaluated by flow cytometry (Darzynkiewicz et al., 1992 , adapted as in Piacentini et al., 1992; Melino et al., 1994) on a FACScan flow cytometer (Becton-Dickinson, San Jose, CA, USA). Cells were excited at 488 nm using a 15 mW Argon laser, and the fluorescence was monitored at 575 nm. Twenty thousand events were triggered by the forward side scatter (FSC) signal and electronically gated for FSC-H/FSC-A/SSC (where H is height, A is area and SSC is side scatter) to exclude cell aggregates. The data then were analysed using the Lysis II program.
Electrophoresis and immunoblotting
Unirradiated and irradiated HJC12 cells were collected by centrifugation, and washed twice in PBS (13.7 mM NaCl, 0.27 mM KCl, 0.43 mM Na 2 HPO 4 7H 2 O, 0.14 mM KH 2 PO 4 (pH 7.3)). Pellets were resuspended in a volume of lysis buffer (50 mM Tris pH 7.4, 5 mM EDTA, 250 mM NaCl, 50 mM NaF, 0.1% Triton X-100, 10 mg/ml Leupeptin and 1 mM phenylmethylsulfonyl fluoride (PMSF)). Cell lysis was achieved after 30 min in ice. Protein concentrations were measured by Bradford assay. Proteins were normalized to 40 mg/lane and were applied to 8% SDS-polyacrylamide gel for PARP detection and to 12.5% SDS-polyacrylamide gel for Bcl-2, Bax, CD95 and CD95L. Proteins (150 mg) were loaded in each lane of an 8% SDS -polyacrylamide gel for p73 detection. The gels were blotted (2 h at 300 mA) onto a Hybond -ECL nitrocellulose filter (Amersham Life Science Inc. Arlington Heights, IL, USA). Kaleidoscope prestained standard (Bio-Rad Laboratories, Hercules, CA, USA) was used to determine molecular weights. The filter was washed twice with TBS-T buffer (2 mM Tris/Cl (pH 7.6), 13.7 mM NaCl, and 0.1% Tween-20) before blocking non-specific binding sites with 1 h incubation in 5% bovine serum albumin (BSA)/TBS-T buffer (2 mM Tris/Cl (pH 7.6), 13.7 mM NaCl, and 0.1% Tween-20). The filter then was incubated for 1 h at room temperature with the specific antibody diluted in 3% BSA/TBS-T buffer (2 mM Tris/Cl (pH 7.6), 13.7 mM NaCl, and 0.1% Tween-20). The antibodies were diluted as follows: anti-human PARP polyclonal antibody (1 : 500), anti-human b-actin (1 : 500), anti-human Bax polyclonal antibody (1 : 500), anti-human Bcl-2 monoclonal antibody (1 : 500), anti-human Bcl-x L polyclonal antibody (1 : 500), anti-human p73a/b monoclonal antibody (1 : 100), anti-human CD95 polyclonal antibody (1 : 500) and anti-human CD95L monoclonal antibody (1 : 500). The nitrocellulose filter was washed twice and detection was performed for 1 h at room temperature using the ECL method (Amersham Life Science Inc.) by horseradish peroxidase-conjugated goat anti-mouse (1 : 20 000) for p73 a/b, Bcl-2 and CD95L or goat anti-rabbit (1 : 20 000) antibody for Bax, Bcl-x L , PARP and CD95. Quantification was performed by scanning laser densitometry.
RT -PCR
Total RNA was prepared using Qiagen total RNA kit. RNA was converted to cDNA by reverse transcription and was amplified for 38 cycles by PCR in a thermocycler (Stratagene) using the Gene Amplification RNA -PCR kit (Perkin-Elmer). Primers used for amplification of the Bcl-2 fragment were prepared according to the sequence of mouse Bcl-2 (Negrini et al., 1987) .
Expression of b-actin was used as an internal standard for RNA integrity. Primers used to amplify the b-actin fragment were: 5'b-actin, 5'-TGGGAATGGGTCAGAAGGACT-3', and 3'b-actin, 5'TTTCACGGTTGGCCTTAGGGT-3'. Equal gel loading and 20 cycles of amplification were performed. PCR products were run at 60 V for 2 h on a 1.2% agarose gel with ethidium bromide and visualized by UV illumination. For p73 transcript analysis, reverse transcription was initially performed using 1 mg of total RNA in 20 ml of standard reaction buffer (Life Technologies), 10 mM DTT, dNTPs 0.5 mM each, primers 1.5 mM each and 1 ml of Thermoscript Reverse Transcriptase (Life Technologies), for 40 min at 558C. The expression pattern of all the p73 splicing variants was detected by radioactive RT -PCR using the following primers: p73A1, 5'-TTCTGCAGGTGACT-CAGGCTG-3' for reverse transcription; p73S5(+), 5'-ACTTTGAGATCCTGATGAAG-3' and p73A6(7), 5'-CAGATGGTCATGCGGTACTG-3' for PCR amplification. cDNA synthesis was performed starting from equal RNA amounts (1 mg). Radioactive PCR reaction was performed in 50 ml of reaction buffer containing 5 ml of the RT product, 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1% Triton X-100, 1.5 mM MgCl 2 , dNTPs 0.2 mM each, cold primers 0.4 mM each, plus 40 nM each of 33 PgdATP labeled primers and 2.5 units of Taq DNA Polymerase (Promega). The amplification consisted of: 1 cycle at 958C for 5' followed by 35 cycles of 958C/60'', 598C/55'', 728C/45''.
b-actin mRNA was reverse transcribed using the primer 3'b-actin, 5'-TTTCACGGTTGGCCTTAGGGT-3', and a fragment amplified using primers 5'b-actin, 5'-TGGGA-ATGGGTCAGAAGGACT-3', and 3'b-actin, 5'-TTTCAC-GGTTGGCCTTAGGGT-3', using the same reagents and conditions as above. Annealing temperature was decreased to 568C with 14 PCR amplification cycles. PCR products were separated on a non-denaturing 6% polyacrylamide gel, dried and analysed by autoradiography.
